Medicus Pharma Warrant
MDCXW
7 hedge funds and large institutions have $33K invested in Medicus Pharma Warrant in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
13,728% more capital inflows, than outflows
Capital inflows: $24.3K | Capital outflows: $176
75% more funds holding
Funds holding: 4 → 7 (+3)
5.9% more ownership
Funds ownership: 11.28% → 17.18% (+5.9%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Private Advisor Group
Morristown,
New Jersey
|
+$18.1K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$6.23K |
| 3 |
Clear Street
New York
|
+$37 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$176 |
MDCXW Hedge Fund Activity: Q3 2026 in Review
7 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q3 2026, worth a combined $33K — down 48% from $63.6K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MDCXW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $18.1K. The largest seller was UBS Group, cutting an estimated $176.
- 7 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q3 2026, up from 4 in Q2 2026.
- Funds reported $33K of Medicus Pharma Warrant stock for Q3 2026, down 48% quarter-over-quarter.
- 3 funds opened new Medicus Pharma Warrant positions in Q3 2026 and 0 closed out, a net change of +3 holders.
- The largest Medicus Pharma Warrant buyer in Q3 2026 was Private Advisor Group, an estimated $18.1K added.
- The largest Medicus Pharma Warrant seller in Q3 2026 was UBS Group, an estimated $176 sold.
Based on aggregated 13F filings for Q3 2026.